SCHEMBL5520904

SCHEMBL5520904

CC(C)[C@@H](CSCc1ccccc1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ACE P12821 3/20 0.52
CYP2C19 P33261 1/20 0.47
PPARG P37231 2/20 0.46
PPARA Q07869 2/20 0.46
MMP1 P03956 1/20 0.45
FCER2 P06734 1/20 0.45
METAP2 P50579 1/20 0.43
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10268771 0.82 ACE (0.58) ACECYP2C19PPARGPPARAMETAP2
SCHEMBL1357871 0.82 ACE (0.58) ACECYP2C19PPARGPPARAMETAP2
SCHEMBL1741031 0.82 ACE (0.58) ACECYP2C19PPARGPPARAMETAP2
SCHEMBL5418068 0.78 CYP1A2 (0.55) ACECYP2C19PPARGPPARA
SCHEMBL28519174 0.78 CYP2C19 (0.46) ACECYP2C19PPARGPPARAMMP1
SCHEMBL9226840 0.77 ACE (0.50) ACECYP2C19PPARGPPARAMMP1
SCHEMBL2162954 0.77 CYP2C19 (0.52) ACECYP2C19PPARGPPARAMETAP2
SCHEMBL5846128 0.77 CYP2C19 (0.52) ACECYP2C19PPARGPPARAMETAP2
SCHEMBL723034 0.77 CYP2C19 (0.52) ACECYP2C19PPARGPPARAMETAP2
SCHEMBL8500821 0.76 CYP1A2 (0.53) ACECYP2C19PPARGPPARAMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed